Zhisong He
People's Bank of China(CN)Chinese Academy of Medical Sciences & Peking Union Medical College(CN)Peking University(CN)Peking Union Medical College Hospital(CN)Peking University Cancer Hospital(CN)Beijing Chest Hospital(CN)Peking University First Hospital(CN)Ministry of Education(ET)Institute of Crop Sciences(CN)State Key Laboratory of Molecular OncologyXi’an Jiaotong-Liverpool University(CN)
Publications by Year
Research Areas
Bladder and Urothelial Cancer Treatments, Esophageal Cancer Research and Treatment, Renal cell carcinoma treatment, Renal and related cancers, Urinary and Genital Oncology Studies
Most-Cited Works
- → Genome-wide association study identifies three new susceptibility loci for esophageal squamous-cell carcinoma in Chinese populations(2011)291 cited
- → Genome-wide association analyses of esophageal squamous cell carcinoma in Chinese identify multiple susceptibility loci and gene-environment interactions(2012)272 cited
- → Open-label, Multicenter, Phase II Study of RC48-ADC, a HER2-Targeting Antibody–Drug Conjugate, in Patients with Locally Advanced or Metastatic Urothelial Carcinoma(2020)270 cited
- → Efficacy of endoscopic screening for esophageal cancer in China (ESECC): design and preliminary results of a population-based randomised controlled trial(2018)133 cited
- → Prognostic significance of the combination of preoperative hemoglobin and albumin levels and lymphocyte and platelet counts (HALP) in patients with renal cell carcinoma after nephrectomy(2018)120 cited
- → Vitamin C increases 5-hydroxymethylcytosine level and inhibits the growth of bladder cancer